Longevity medicine focuses on developing advanced medical interventions aimed at delaying the onset of age-related diseases and extending human lifespan. This includes research into senolytics, stem cell therapies, and gene editing techniques.
Aging and the diseases associated with it, such as Alzheimer's, cardiovascular disease, and cancer, which significantly impact quality of life and healthcare costs.
Technologies such as senolytics target and eliminate senescent cells that contribute to aging and disease progression. Stem cell therapies involve using pluripotent or induced pluripotent stem cells to regenerate damaged tissues. Gene editing aims to correct genetic mutations associated with age-related conditions.
Primarily involves laboratory research and development in biotechnology. Initial stages may include cell culture, genetic modification, and clinical trials to validate safety and efficacy.
Involves the cultivation of cells, gene editing using CRISPR or other techniques, testing for senescence markers, and developing delivery systems for therapeutic agents.
Curated names only — none are invented. Use the link to find more.
Cost drivers only — no verified dollar figures are shown. Check live sources for prices.
Illustrative — search real, dated examples rather than trusting a generated story.
Live searches — we don't list papers we can't verify.
Live patent searches — filings are never listed from memory.
Verify against primary sources only.
Source: curated technology intelligence stream with tracked references.